Ignite Creation Date:
2025-12-25 @ 2:22 AM
Ignite Modification Date:
2026-02-28 @ 9:32 AM
Study NCT ID:
NCT06679634
Status:
RECRUITING
Last Update Posted:
2025-04-03
First Post:
2024-11-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Retinoblastoma Phase II Expanded Access Clinical Trial
Sponsor:
Targeted Therapy Technologies, LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-02-21
Start Date Type:
ACTUAL
Primary Completion Date:
2028-11
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-11
Completion Date Type:
ESTIMATED
First Submit Date:
2024-11-05
First Submit QC Date:
None
Study First Post Date:
2024-11-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-04-01
Last Update Post Date:
2025-04-03
Last Update Post Date Type:
ACTUAL